NCT03588975 - A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 24, 2018

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions

Chondral DefectOsteochondritis Dissecans (OCD)Articular Cartilage DefectArticular Cartilage Disorder of Knee

Interventions

BIOLOGICAL

MACI

autologous cultured chondrocytes on porcine collagen membrane

PROCEDURE

microfracture

Arthroscopic microfracture treatment

Trial Locations (12)

19104

RECRUITING

Children's Hospital of Philadelphia, Philadelphia

RECRUITING

Penn Sports Medicine Center, Philadelphia

21224

RECRUITING

Johns Hopkins Outpatient Center, Baltimore

43202

RECRUITING

The Ohio State University Jameson Crane Sports Medicine Institute, Columbus

44308

RECRUITING

Akron Children's Hospital, Akron

48106

RECRUITING

University of Michigan, Ann Arbor

53201

RECRUITING

Medical College of Wisconsin, Milwaukee

70121

RECRUITING

Ochsner Sports Medicine Institute, New Orleans

77094

WITHDRAWN

Texas Children's Hospital, Houston

94304

RECRUITING

Stanford University, Palo Alto

95817

RECRUITING

Shriner's Hospital for Children Northern California, Sacramento

RECRUITING

University of California Davis Health, Sacramento

All Listed Sponsors

lead

Vericel Corporation

INDUSTRY